HS-10342 / Jiangsu Hansoh Pharma - LARVOL DELTA

A Study of HS-10342 in Patients With Advanced Solid Tumor (clinicaltrials.gov) - P1 | N=17 | Completed | Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Unknown status ➔ Completed | N=36 ➔ 17

Enrollment change • Trial completion • Oncology • Solid Tumor

A Study of HS-10342 in Chinese Patients With HR+/HER2- Advanced and/or Metastatic Breast Cancer (clinicaltrials.gov) - P2; N=20; Not yet recruiting; Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.

Clinical • New P2 trial • Breast Cancer • HER2 Breast Cancer • HER2 Negative Breast Cancer • Hormone Receptor Breast Cancer • Hormone Receptor Positive Breast Cancer • Oncology • Solid Tumor • HER-2

Newly added product (clinicaltrials.gov) - P1, Solid Tumor

Pipeline update